Dexedrine (dextroamphetamine) is a potent central nervous system (CNS) stimulant for the treatment of attention-deficit hyperactivity (ADHD) in children and adults, and narcolepsy (loss of the brain's ability to regulate sleep-wake cycles normally). Dexedrine has potential for abuse and should only be used as prescribed.

Dosage FAQs

Possible Side Effects

Dexedrine, like many other psychostimulants, may cause a range of side effects. If you experience any of the following side effects, contact your physician to see if your dosage or treatment need adjustment:

Adverse Drug Interactions

If you are prescribed this drug, ensure that you discuss all medications, vitamins, and supplements you take on a regular basis with your doctor and pharmacist. This medication may interact with the following substances:

Precautions Before Use

This medication may impair performance. You should avoid high-risk tasks like driving, operating heavy machinery, or climbing until you are aware of how this drug will affect you. Dexedrine should be avoided by those experiencing the following conditions:

Chemistry

Dexedrine is a non-catecholamine, sympathomimetic amine and has a stimulating effect on the central nervous system. It is a dextrorotary isomer of amphetamine. It exists as a crystalline powder that is white in color. Dexedrine is odorless and bitter in taste. It is freely soluble in water and slightly soluble in alcohol.

Safe Withdrawal from Dexedrine

This drug has high potential for abuse and dependency. Because of this, if you need to stop taking this medication you should develop a safe plan with your health care provider to taper down your dosage and reduce the occurrence and severity of withdrawal symptoms. In general, the longer you take this medication and the higher your dose, the more discomfort you will experience during withdrawal. Symptoms of withdrawal may include:

References:

  1. Nissen SE. ADHD drugs and cardiovascular risk. New England Journal of Medicine. 2006; 354:1445-1448.
  2. Asherson P. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Review of Neurotherapeutics. 2005; 5:525-539.
  3. Williams RJ, Goodale LA, Shay-Fiddler MA, et al. Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents. American Journal on Addictions. 2004;13(4):381-389.
  4. Wilens T. Data presented at symposium at the 158th Annual American Psychiatric Association Meeting; May 21, 2005.
  5.  Biederman J. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youth with and without ADHD. Journal of Clinical Psychiatry. 2003;64(suppl 11):3-8

Page content reviewed by James Pendleton, ND.